DiaSorin

Saluggia, Italy Founded: 1968 • Age: 58 yrs
Reagent kits for in vitro diagnostics are developed and commercialized.
Request Access

About DiaSorin

DiaSorin is a company based in Saluggia (Italy) founded in 1968.. The company has 30 employees as of March 28, 2024. DiaSorin has completed 2 acquisitions, including Focus DX and Luminex Corporation. DiaSorin offers products and services including LIAISON XL, VERIGENE System, MAGPIX System, and Simplexa COVID-19 & Flu A/B.

  • Headquarter Saluggia, Italy
  • Employees 30 as on 28 Mar, 2024
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Diasorin Healthcare India Private Limited
  • Date of Incorporation 10 Jul, 2012
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
    $6.6 M (USD)
    42.93
    as on Mar 31, 2022
  • Net Profit
    $750.4 K (USD)
    30.1
    as on Mar 31, 2022
  • EBITDA
    $1.37 M (USD)
    23.2
    as on Mar 31, 2022
  • Latest Funding Round
  • Investors
    HHS

    & 1 more

  • Employee Count
    30

    as on Mar 28, 2024

  • Investments & Acquisitions
    Focus DX

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of DiaSorin

DiaSorin offers a comprehensive portfolio of products and services, including LIAISON XL, VERIGENE System, MAGPIX System, and Simplexa COVID-19 & Flu A/B. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Instrument for immunodiagnostic testing of infectious diseases

System for detecting pathogens in biological samples

Platform for bead-based multiplexing in diagnostics

Kit for identifying respiratory viruses quickly

People of DiaSorin
Headcount 1000-5000
Employee Profiles 94
Board Members and Advisors 1
Employee Profiles
People
Josh Glason
Vice President Asia Pacific
People
Sandeep Kumar
Regional Sales Manager
People
Jesse Nergard
Director Of Talent Acquisition, North America
People
Marco Pogliano
Assay Transfer Team Senior Manager Italy&uk

Unlock access to complete

Board Members and Advisors
people
Michele Denegri
Chairman

Unlock access to complete

Funding Insights of DiaSorin

  • Total Funding
  • Total Rounds 5
  • Last Round
  • First Round

    (17 Mar 2009)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2021 Amount Grant - DiaSorin Valuation

investors

Dec, 2020 Amount Grant - DiaSorin Valuation

investors

Nov, 2020 Amount Grant - DiaSorin Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in DiaSorin

DiaSorin has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Public Health Emergency. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by DiaSorin

DiaSorin has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Focus DX and Luminex Corporation. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Developer of instruments, reagents and kits for clinical diagnostics and life science research
1995
Diagnostic assays and reagents for infectious diseases are developed.
1978
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - DiaSorin

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Diasorin Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of DiaSorin

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Diasorin

Frequently Asked Questions about DiaSorin

When was DiaSorin founded?

DiaSorin was founded in 1968 and raised its 1st funding round 41 years after it was founded.

Where is DiaSorin located?

DiaSorin is headquartered in Saluggia, Italy. It is registered at Saluggia, Piemonte, Italy.

How many employees does DiaSorin have?

As of Mar 28, 2024, the latest employee count at DiaSorin is 30.

What is the annual revenue of DiaSorin?

Annual revenue of DiaSorin is $6.6M as on Mar 31, 2022.

What does DiaSorin do?

DiaSorin was founded in 1968 in Saluggia, Italy. Reagent kits for in vitro diagnostics are developed and commercialized, with emphasis on immunodiagnostics and molecular diagnostics sectors. These kits are applied in hospital and private testing laboratories for infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology, and endocrinology. Offices are operated in Europe, the United States, Central and South America, Asia, and South Africa as of January 2016.

What products or services does DiaSorin offer?

DiaSorin offers LIAISON XL, VERIGENE System, MAGPIX System, and Simplexa COVID-19 & Flu A/B.

How many acquisitions has DiaSorin made?

DiaSorin has made 2 acquisitions, including Focus DX, and Luminex Corporation.

Who are DiaSorin's investors?

DiaSorin has 2 investors. Key investors include HHS, and Public Health Emergency.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available